Is the time for an AIDS-free new generation different in resource-limited and industrialized countries?

AIDS

Volumn 23, Issue 3, 2009, Pages 293-296

  Russo, Gianluca ^a,b   Lichtner, Miriam ^a   Traditi, Fiore ^a   Vullo, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Antiretroviral therapy; HIV; Pregnancy; Prevention of mother to child transmission; Resource limited countries

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DIAGNOSTIC TEST; DISEASE CONTROL; DISEASE TRANSMISSION; DRUG COMBINATION; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDUSTRIALIZATION; INTRAUTERINE INFECTION; NOTE; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; RISK REDUCTION; SOUTH AFRICA; THREE DRUG COMBINATION ANTIRETROVIRAL THERAPY; VERTICAL TRANSMISSION; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEVELOPED COUNTRIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MEDICALLY UNDERSERVED AREA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE;

EID: 59849101156     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32831c54aa     Document Type: Note

References (26)

1. WHO. Antiretroviral Therapy for HIV infection in adults and adolescents: toward universal access. Recommendations for a public health approach. Geneva: WHO; 2006.
2. Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. 29 January 2008. pp. 1-128. Available at http://www.aid-sinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf.
3. WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited countries: towards universal access. Recommendations for a public health approach. Geneva: WHO; 2006.
4. Public Health Service Task Force. Perinatal HIV Guidelines Working Group. Recommendations for use of antiretroviral drugs in pregnant HIV1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States; 2 November 2007.
5. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. CID 2005; 40:458-465.
6. Recomendações para Profilaxia da Transmissão Vertical do HIV e Terapia Antiretroviral em Gestantes [Recommendations for prophylaxis for vertical transmission of HIV and antiretroviral therapy in pregnant women]. Brazil: Ministry of Health; 2003.
7. WHO/UNAIDS/UNICEF 2007. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report. April 2007. Available at www.who.int/hiv mediacentre/univeral-access-progress-report-en.pdf.
8. UNAIDS/WHO 2007. AIDS epidemic update. December 2007. Available at http://data.unaids.org/pub/EpiReport/2007/2007-EpiUpdate-en.pdf.
9. UNAIDS/WHO 2003. AIDS epidemic update. December 2003. Available at http://data.unaids.org/pub/EpiReport/2003/2003-EpiUpdate-en.pdf.
10. Manzi M, Zachariah R, Teck R, et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow-up in a prevention of mother-to-child transmission programme in rural Malawi: scaling up requires a different way of acting. Trop Med Int Health 2005; 12:1242-1250.
11. Reithinger R, Megazzini K, Durako SJ, Harris DR, Vermund SH. Monitoring and evaluation of programmes to prevent mother-to- child transmission of HIV in Africa. BMJ 2007; 334:1143-1146.
12. Leroy V, Ekouevi DK, Becquet R, et al. 18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breast-feeding to prevent HIV mother-to-child transmission. PLoS ONE2008; 3:e1645. doi: 10.1371/joumal.- pone.0001645.
13. Ekouevi DK, Coffie PA, Becquet R, et al. Antiretroiviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Cote d'lvoire. AIDS 2008; 22:1815- 1820.
14. Hitti J, Frenkel LM, Stek AM, et al. Maternal toxicity with continuous nevirapine in pregnancy [results from PACTG 1022]. J Acquir Immune Defic Syndr 2004; 36:772-776.
15. João EC, Calvet GA, Menezes JA, et al. Nevirapine toxicity in a cohort of HIV-1 infected pregnant women. Am I Obstetr Gynaecol 2006; 194:199-202.
16. Marazzi MC, Germano P, Liotta, et al. Safety of nevirapine- containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women. HIV Med 2006; 7:338-344.
17. Arrive E, Newell ML, Ekouevi DK, et al., for Ghent Group on HIV in Women and Children. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol 2007; 36:1009-1021.
18. Turriziani O, Russo G, Lichtner M, et al. Study of the genotypic resistant pattern in HIV-infected women and children from rural west Cameroon. AIDS Res Hum Retroviruses 2008; 24:781-785.
19. Lockman S, Shapiro RL, Smeaton LM, et al. Response to antiretroviral therapy after a single peripartum dose of nevirapine. N Engl I Med 2007; 356:135-147.
20. Jourdain G, Ngo-Giang-Huong N, Le Coeur S. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 2004; 351:229-240.
21. Wind-Rotolo M, Durand C, Cranmer L, et al. Identification of nevirapine-resistant HIV-1 in the latent reservoir following single-dose nevirapine. CROI 2008. Session 106 [Resistance associated with ART for PMTCT]. Abstract 634.
22. Mofenson LM. Antiretroviral prophylaxis to reduce breast milk transmission of HIV type 1: new data but still questions. J Acquir Immune Defic Syndr 2008; 3:237-240.
23. Palombi L, Marazzi MC, Voetberg A, Magid NA. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS 2007; 21 (Suppl 4):S65-S71.
24. Thomas T, Masaba R, Ndivo R, et al. Prevention of mother-to- child transmission of hiv-1 among breastfeeding mothers using HAART: the Kisumu Breastfeeding Study, Kisumu, Kenya, 2003-2007. CROI 2008. Session 14 [Prevention Mother-to- Child Transmission]. Abstract 45aLB.
25. Kilewo C, Karlsson K, Ngarina M, et al. Prevention of mother- to-child transmission of HIV-1 through breastfeeding by treating mothers prophylactically with triple antiretroviral therapy in Dar es Salaam, Tanzania - the MITRA plus study. In: 4th International AIDS Society Conference on HIV Pathogenesis; Treatment and Prevention: Sydney, Australia, 22-25 July 2007. Abstract TuAX101.
26. Arendt V, Ndimubanzi P, Vyankandonera J, et al. AMATAstudy: effectiveness of antiretroviral therapy in breastfeeding mothers to prevent postnatal vertical transmission in Rwanda. In: 4th International AIDS Society Conference on HIV Pathogenesis; Treatment and Prevention: Sydney, Australia, 22-25 July 2007. Abstract TuAX102.